Tuoxin Pharmaceutical Announces Major Asset Restructuring Ahead of Trading Resumption
Tuoxin Pharmaceutical Group Co Ltd is planning a significant asset restructuring, amidst a dynamic market environment with strong performance in the pharmaceutical sector, and will resume trading on May 19, 2025.
2 minutes to read